| Real‐world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors E Hassan, L Jonathan, M Jayashree Haemophilia 27 (6), e698-e703, 2021 | 16 | 2021 |
| Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK. E Hassan, J Motwani Haemophilia 27 (5), 2021 | 10 | 2021 |
| Breakthrough bleeding episodes in pediatric severe hemophilia A patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review E Hassan, J Motwani Pediatric Hematology and Oncology 39 (5), 418-426, 2022 | 8 | 2022 |
| Impact of the COVID-19 pandemic on health-related quality of life and anxiety in pediatric hematology/oncology patients E Hassan, D Nagui Rizk, NM Aly, Y El Chazli Pediatric hematology and oncology 38 (8), 683-694, 2021 | 5 | 2021 |
| Emicizumab in previously untreated and minimally treated infants. E Hassan, J Lancashire, J Motwani Haemophilia 28 (2), 2022 | 4 | 2022 |
| Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism E Hassan, J Motwani Thrombosis Research 221, 92-96, 2023 | 3 | 2023 |
| Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence? E Hassan, J Lancashire, J Motwani Haemophilia 28 (2), 2022 | 1 | 2022 |
| Positive impact of clinical audit on appropriateness of laboratory investigations for glucose-6-phosphate dehydrogenase-deficient patients in the emergency department E Hassan, G Foulath, M Abdelghany, I Sayed, D Elkhity, Y El Chazli Indian Journal of Pediatrics 88, 859-863, 2021 | 1 | 2021 |
| Surgical management of paediatric patients on emicizumab prophylaxis E Hassan, J Motwani BRITISH JOURNAL OF HAEMATOLOGY 193, 29-29, 2021 | 1 | 2021 |
| Impact of the COVID-19 Pandemic on Health-Related Quality of Life and Anxiety in Pediatric Hematology/Oncology Patients: A Single Egyptian Center Experience E Hassan, DN Rizk, NM Aly, YE Chazli | 1 | 2020 |
| Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age E Hassan, J Motwani Pediatric Blood & Cancer 71 (6), e30941, 2024 | | 2024 |
| Single Centre Study on Safety and Efficacy of Rivaroxaban in Paediatric Venous Thromboembolism E Hassan, M Khakwani, J Motwani BRITISH JOURNAL OF HAEMATOLOGY 197, 168-170, 2022 | | 2022 |
| Thrombopoietin receptor agonists for treatment of new and relapsed immune thrombocytopenia in children-A single-centre experience E Hassan, J Motwani British Journal of Haematology, 166-166, 2022 | | 2022 |
| Assessment of Caregivers' Burden of Children with Haemophilia A on Emicizumab Prophylaxis: Single Centre Study E Hassan, J Motwani BRITISH JOURNAL OF HAEMATOLOGY 197, 48-49, 2022 | | 2022 |
| Positive Impact of Covid-19 on Providing Health Care Services: Experience from a Large Haemophilia Comprehensive Care Centre E Whiting, E Hassan, J Motwani British Journal of Haematology, 167-168, 2022 | | 2022 |
| Single center experience on safety and tolerability of emicizumab in the paediatric population with severe haemophila A E Hassan, J Motwani BRITISH JOURNAL OF HAEMATOLOGY 193, 33-33, 2021 | | 2021 |
| Real-world data about Bleeding outcomes and joint health of paediatric severe haemophilia A patients on emicizumab prophylaxis E Hassan, J Motwani BRITISH JOURNAL OF HAEMATOLOGY 193, 30-30, 2021 | | 2021 |
| Laboratory monitoring of paediatric patients on emicizumab prophylaxis: experience from a large comprehensive haemophilia center in the UK E Hassan, S Westwood, J Motwani BRITISH JOURNAL OF HAEMATOLOGY 193, 33-34, 2021 | | 2021 |
